AMG Funds’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$650K Sell
10,788
-366
-3% -$22K 3.26% 8
2020
Q2
$656K Sell
11,154
-2,689
-19% -$161K 3.35% 9
2020
Q1
$772K Sell
13,843
-11,621
-46% -$710K 3.67% 3
2019
Q4
$1.64M Buy
25,464
+4,077
+19% +$233K 2.57% 8
2019
Q3
$1.08M Sell
21,387
-911
-4% -$42.8K 1.39% 29
2019
Q2
$1.01M Sell
22,298
-1,984
-8% -$92.4K 1.08% 37
2019
Q1
$1.16M Buy
+24,282
New +$1.21M 1.13% 30

Other funds holding BMY

AMG Funds's BMY Position: Q3 2020 in Review

AMG Funds reduced its Bristol-Myers Squibb (BMY) stake by 3.3% in Q3 2020, selling an estimated $22K and leaving 10,788 shares worth $650K. The position accounts for 3.26% of the portfolio, ranked #8.

AMG Funds first reported a position in BMY in Q1 2019 and has held it in 7 quarters since. The position peaked at $1.64M in Q4 2019. 2,215 funds tracked by Wall St. Rank hold BMY as of Q3 2020.

  • AMG Funds held 10,788 shares of Bristol-Myers Squibb worth $650K as of Q3 2020.
  • AMG Funds sold 366 Bristol-Myers Squibb shares in Q3 2020, an estimated $22K.
  • Bristol-Myers Squibb made up 3.26% of AMG Funds's portfolio in Q3 2020, its #8 holding.
  • AMG Funds first reported a position in Bristol-Myers Squibb in Q1 2019 and has held it in 7 quarters since.
  • AMG Funds's Bristol-Myers Squibb position peaked at $1.64M in Q4 2019.
  • 2,215 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2020.

Based on AMG Funds's 13F filing for Q3 2020, filed 12 Nov 2020.